Effect of simvastatin treatment on the dyslipoproteinemia in capd patients
- 28 February 1991
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 86 (2-3) , 183-192
- https://doi.org/10.1016/0021-9150(91)90214-n
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding proteinNature, 1989
- INHIBITION OF PLATELET AGGREGATION BY ABNORMAL HIGH DENSITY LIPOPROTEIN PARTICLES IN PLASMA FROM PATIENTS WITH HEPATIC CIRRHOSISThe Lancet, 1989
- Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levelsHuman Genetics, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1986
- SYNVINOLIN IN HYPERCHOLESTEROLAEMIAThe Lancet, 1986
- Levels of lipoprotein Lp(a) decline with neomycin and niacin treatmentAtherosclerosis, 1985
- Serum lipids and apolipoproteins A‐I, A‐II and B in primary hypothyroidism before and during treatmentEuropean Journal of Clinical Investigation, 1984
- Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a)Atherosclerosis, 1982